The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

6 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Antibody-drug conjugates for targeted cancer therapy: Recent advances in potential payloads.EBI
Shaoxing University
Therapeutic potential of targeting kynurenine pathway in neurodegenerative diseases.EBI
Shaoxing University
Design, synthesis, biological evaluation and molecular modeling of N-isobutyl-N-((2-(p-tolyloxymethyl)thiazol-4yl)methyl)benzo[d][1,3] dioxole-5-carboxamides as selective butyrylcholinesterase inhibitors.EBI
Shaoxing University
Therapeutic potential of phosphodiesterase inhibitors for cognitive amelioration in Alzheimer's disease.EBI
Shaoxing University
CDK8 as a therapeutic target for cancers and recent developments in discovery of CDK8 inhibitors.EBI
Shaoxing University
Small molecule PROTACs in targeted therapy: An emerging strategy to induce protein degradation.EBI
Shaoxing University